TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 183.80
+10.20 (5.88%)
Oct 31, 2025, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 72.95 billion as of October 31, 2025.
Market Cap
72.95B
Enterprise Value
72.25B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
183.80
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 72.95B, an increase of 682.13%. That is a compound annual growth rate of 33,589.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 68.90B | -5.40% |
| Oct 28, 2025 | 72.83B | -3.42% |
| Oct 27, 2025 | 75.41B | -0.52% |
| Oct 24, 2025 | 75.81B | 1.70% |
| Oct 23, 2025 | 74.54B | -2.19% |
| Oct 22, 2025 | 76.20B | 11.18% |
| Oct 21, 2025 | 68.54B | -11.48% |
| Oct 20, 2025 | 77.43B | -3.89% |
| Oct 17, 2025 | 80.57B | 22.22% |
| Oct 16, 2025 | 65.92B | 46.34% |
| Oct 15, 2025 | 45.05B | 0.53% |
| Oct 14, 2025 | 44.81B | -4.16% |
| Oct 13, 2025 | 46.75B | -1.42% |
| Oct 10, 2025 | 47.43B | -9.95% |
| Oct 9, 2025 | 52.67B | -4.39% |
| Oct 8, 2025 | 55.09B | 0.58% |
| Oct 6, 2025 | 54.77B | 1.40% |
| Oct 3, 2025 | 54.02B | - |
| Oct 2, 2025 | 54.02B | -3.61% |
| Sep 30, 2025 | 56.04B | 0.28% |
| Sep 29, 2025 | 55.88B | -1.68% |
| Sep 26, 2025 | 56.84B | -10.39% |
| Sep 25, 2025 | 63.42B | -1.66% |
| Sep 24, 2025 | 64.50B | -1.57% |
| Sep 23, 2025 | 65.53B | 11.78% |
| Sep 22, 2025 | 58.62B | -1.47% |
| Sep 19, 2025 | 59.49B | -18.18% |
| Sep 18, 2025 | 72.71B | -12.43% |
| Sep 17, 2025 | 83.03B | 8.96% |
| Sep 16, 2025 | 76.20B | -53.73% |
| Sep 15, 2025 | 164.71B | 115.58% |
| Sep 12, 2025 | 76.40B | 77.09% |
| Sep 11, 2025 | 43.14B | 20.78% |
| Sep 10, 2025 | 35.72B | 27.57% |
| Sep 9, 2025 | 28.00B | -6.93% |
| Sep 8, 2025 | 30.08B | 20.13% |
| Sep 5, 2025 | 25.04B | 5.43% |
| Sep 4, 2025 | 23.75B | -0.33% |
| Sep 3, 2025 | 23.83B | -4.98% |
| Sep 2, 2025 | 25.08B | 8.97% |
| Sep 1, 2025 | 23.02B | 7.11% |
| Aug 29, 2025 | 21.49B | 6.18% |
| Aug 28, 2025 | 20.24B | -5.12% |
| Aug 27, 2025 | 21.33B | 0.09% |
| Aug 26, 2025 | 21.31B | -0.09% |
| Aug 25, 2025 | 21.33B | -1.83% |
| Aug 22, 2025 | 21.73B | -0.09% |
| Aug 21, 2025 | 21.75B | 6.61% |
| Aug 20, 2025 | 20.40B | -0.58% |
| Aug 19, 2025 | 20.52B | -4.26% |
| Aug 18, 2025 | 21.43B | 6.93% |
| Aug 15, 2025 | 20.04B | 5.65% |
| Aug 14, 2025 | 18.97B | -6.27% |
| Aug 13, 2025 | 20.24B | 5.63% |
| Aug 12, 2025 | 19.16B | 12.17% |
| Aug 11, 2025 | 17.08B | -1.91% |
| Aug 8, 2025 | 17.42B | -0.05% |
| Aug 7, 2025 | 17.42B | 0.60% |
| Aug 6, 2025 | 17.32B | 0.46% |
| Aug 5, 2025 | 17.24B | 2.21% |
| Aug 4, 2025 | 16.87B | 10.53% |
| Aug 1, 2025 | 15.26B | 1.32% |
| Jul 31, 2025 | 15.06B | -3.92% |
| Jul 30, 2025 | 15.68B | -3.42% |
| Jul 29, 2025 | 16.23B | 6.37% |
| Jul 28, 2025 | 15.26B | 3.22% |
| Jul 25, 2025 | 14.78B | 16.41% |
| Jul 24, 2025 | 12.70B | 1.91% |
| Jul 23, 2025 | 12.46B | 0.32% |
| Jul 22, 2025 | 12.42B | -1.57% |
| Jul 21, 2025 | 12.62B | -4.36% |
| Jul 18, 2025 | 13.20B | 3.74% |
| Jul 17, 2025 | 12.72B | 0.79% |
| Jul 16, 2025 | 12.62B | 0.32% |
| Jul 15, 2025 | 12.58B | 7.82% |
| Jul 14, 2025 | 11.67B | -2.00% |
| Jul 11, 2025 | 11.91B | - |
| Jul 10, 2025 | 11.91B | -2.76% |
| Jul 9, 2025 | 12.24B | 1.15% |
| Jul 8, 2025 | 12.11B | -6.15% |
| Jul 7, 2025 | 12.90B | -4.27% |
| Jul 4, 2025 | 13.47B | 16.87% |
| Jul 3, 2025 | 11.53B | 4.68% |
| Jul 2, 2025 | 11.01B | -7.96% |
| Jun 30, 2025 | 11.97B | 8.65% |
| Jun 27, 2025 | 11.01B | 5.51% |
| Jun 26, 2025 | 10.44B | 5.20% |
| Jun 25, 2025 | 9.92B | 3.31% |
| Jun 24, 2025 | 9.60B | 2.98% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.63B |
| Hansoh Pharmaceutical Group Company | 215.76B |
| JD Health International | 194.33B |
| Innovent Biologics | 149.08B |
| WuXi Biologics | 147.15B |
| Sino Biopharmaceutical | 126.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.47B |
| Akeso | 104.46B |